Botanical

Horny Goat Weed (Epimedium)

Also called Epimedium, yin yang huo, icariin, Epimedii folium, barrenwort

By Kymata Labs EditorialMedical review pendingLast reviewed October 13, 2026 · What changed

Kymata Health may earn a commission from links on separate product pages. This page contains no product links. Educational reference, not medical advice.

Summary

Horny goat weed is sold for sexual function, but no published placebo-controlled human trial of Epimedium alone was found for erections or libido. The best human data are bone studies in postmenopausal women (grade C). Icariin's PDE5 effect comes from lab tests, case reports describe serious reactions, and some products have contained hidden sildenafil.

Top graded outcomes:C evidence grade Spine and hip bone mineral density in late postmenopausal womenD evidence grade Safety and a bone-formation marker (BSAP) with an Epimedium prenylflavonoid extractD evidence grade Symptom severity, pain and fatigue in Gulf War illness

Key facts

Main marker compound
Icariin, a prenylated flavonoid; extracts are commonly standardized to 10–20% icariin[10][3]
Sexual-function trials
None found for Epimedium alone in people; erection data come from enzyme tests and a rat study[4][5]
Best human evidence
A 24-month trial in 100 postmenopausal women: icariin 60 mg/day plus soy isoflavones kept spine and hip bone density stable while placebo lost bone[1]
What reaches the blood
After an Epimedium prenylflavonoid extract, icariin itself was below detection; desmethylicaritin was the main metabolite[2]
Product purity
FDA has posted a recall of a 'horny goat weed' capsule found to contain undeclared sildenafil and a sildenafil analogue[9]
Evidence base
3 graded human outcomes on this page
Last reviewed
October 13, 2026

How it works

ProposedIn lab tests icariin inhibits PDE5, the enzyme blocked by sildenafil, but about 80 times more weakly than its chemically modified derivative, which matched sildenafil. In nerve-injured rats, oral icariin improved erectile pressure responses. Neither effect has been confirmed with Epimedium in people.[4][5]

What the human research says

Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.

At a glance: strongest evidence per outcome

Evidence at a glance: strongest human evidence per outcome
OutcomeGradeEffectStrongest evidenceRows
BoneGrade CImprovedRCT · n = 85 · 2007Form tested: Epimedium-derived flavonoids: icariin 60 mg, daidzein 15 mg and genistein 3 mg daily2 rowsIncludes this form
FatigueGrade DNo effectPilot RCT · n = 10 · 2021Form tested: Epimedium sagittatum extract standardized to 20% icariin1 rowIncludes this form

Every graded row

Outcome
Grade
Form tested
Sort

Showing 3 of 3 outcomes. Human trials only.

OutcomeEffectGradeBest evidencePMID
Spine and hip bone mineral density in late postmenopausal womenImprovedGrade C

RCT · n = 85 · 2007

Healthy late postmenopausal women with low bone density (T-score −2 to −2.5), Hong Kong

Form: Epimedium-derived flavonoids: icariin 60 mg, daidzein 15 mg and genistein 3 mg daily · Dose: One daily dose of the flavonoid mix; all participants also received 300 mg calcium · Duration: 24 months

Bone density stayed stable with the flavonoids while the placebo group lost 2.4% at the lumbar spine and 1.8% at the femoral neck; between-group differences were significant at 24 months. A bone-breakdown marker fell 39–43%. Estradiol and endometrial thickness did not change.

17419678 (opens PubMed)Source [1]
Safety and a bone-formation marker (BSAP) with an Epimedium prenylflavonoid extractImprovedGrade D

RCT · n = 58 · 2021

Healthy postmenopausal women aged about 58 (Singapore)

Form: Purified Epimedium prenylflavonoid extract · Dose: 740 mg/day · Duration: 6 weeks

No significant adverse symptoms and no changes in liver, blood or kidney tests. Prenylflavonoid intake was associated with higher bone-specific alkaline phosphatase (p<0.05) and a non-significant trend toward lower TRAF6, an osteoclast marker.

34352588 (opens PubMed)Source [2]
Symptom severity, pain and fatigue in Gulf War illnessNo effectGrade D

Pilot RCT · n = 10 · 2021

Men with Gulf War illness (USA)

Form: Epimedium sagittatum extract standardized to 20% icariin · Dose: 500 mg/day then 1,000 mg/day (100 and 200 mg icariin) · Duration: 30 days per dose level after 30 days of placebo

Neither the lower nor the higher dose reduced symptom severity compared with placebo.

33915962 (opens PubMed)Source [3]

Forms

FormElemental %Absorption (human data)GI toleranceStudied for
Extract standardized to icariin (10–20%)Varies[10][3]Not applicable (botanical extract; icariin is a marker, 10–20% by weight)Icariin was not detectable in blood after an Epimedium flavonoid extract; it is converted to metabolites such as desmethylicaritin and icaritin.[2]The Gulf War illness study abstract reports no Epimedium-specific adverse effects; case reports describe muscle injury and psychosis with over-the-counter products.[3][6][7]Gulf War illness symptoms (500–1,000 mg/day of a 20% icariin extract)
Purified Epimedium prenylflavonoid extractVaries[2]Not applicable (botanical extract)Desmethylicaritin peaked at a median 60.9 nM; icariin and icariside I stayed below detection.[2]No significant adverse symptoms and no liver, blood or kidney test changes over 6 weeks.[2]Safety and bone markers in postmenopausal women (740 mg/day)
Icariin with soy isoflavonesVaries[1]Not applicable (60 mg icariin, 15 mg daidzein, 3 mg genistein per day)No head-to-head human absorption data.[1]No change in estradiol or endometrial thickness over 24 months.[1]Bone density in postmenopausal women (24 months)

Studied doses

Doses studied in human trials ranged from 60 mg/day of icariin (with soy isoflavones) for 24 months, to 740 mg/day of a prenylflavonoid extract for 6 weeks, and 500–1,000 mg/day of a 20% icariin extract (100–200 mg icariin) for 30 days at each level. No trial has tested Epimedium alone for sexual function.[1][2][3]

These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Interactions

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

Medicines

  • Nitrates (with adulterated products)FDA safety communicatione.g. Nitroglycerin and other nitrate heart medicinesFDA posted a recall of a 'horny goat weed' capsule containing undeclared sildenafil, warning that it may interact with nitrates and cause a life-threatening drop in blood pressure. This applies to tainted products, not to Epimedium itself.[9]
  • Buprenorphine and other CYP3A4-metabolized drugsCase reporte.g. BuprenorphineOne case report describes worse opioid cravings after starting Herba Epimedii during buprenorphine treatment; the authors propose a CYP3A4 interaction based on lab data.[8]
  • Dopaminergic Parkinson's medicinesCase reporte.g. Ropinirole, carbidopa/levodopaOne case report describes new psychosis in a person with Parkinson's disease after a month of daily horny goat weed; the authors suggest CYP1A2 inhibition may have raised ropinirole levels, but the product's contents were unknown.[6]

Who should be careful

People who use nitrate heart medicines
Some products sold as horny goat weed have contained hidden sildenafil, which the recall notice posted by FDA warns can drop blood pressure dangerously with nitrates.[9]
Parkinson's disease or other dopaminergic therapy
A case report links daily horny goat weed to new psychosis in a person taking ropinirole and levodopa.[6]
People taking buprenorphine
A case report describes increased opioid cravings after starting Herba Epimedii.[8]
Pregnancy and breastfeeding
The cited trials enrolled postmenopausal women or adult men, so they give no safety data for these groups; product labels advise consulting a professional first.[1][2][3][10]
Unexplained muscle pain or cramps
A 33-year-old man developed severe muscle spasms with creatine kinase up to 3,271 U/L and raised creatinine after a month of an online Epimedium product; both improved in hospital after he stopped it.[7]

Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

How to read the label

  1. Label dose vs studied doseA typical label (500 mg extract at 10% icariin, one capsule twice daily) gives about 100 mg icariin a day. That matches the lower dose in the Gulf War illness study, which found no benefit, and exceeds the 60 mg/day used in the bone trial.[10][3][1]
  2. Check the icariin percentageExtracts in studies and on labels range from 10% to 20% icariin, so the same extract weight can give twice the icariin.[10][3]
  3. Beware of multi-ingredient 'male enhancement' productsFDA has posted a recall of a horny goat weed capsule that contained undeclared sildenafil and a sildenafil analogue.[9]

Cost per studied dose, without the sales pitch

Compare any product you already have by the amount it delivers, not by capsule count or front-of-pack weight.

Cost per studied dose

Enter the price, servings and the amount per serving from your label.

Formula: price ÷ (servings × amount per serving) × reference amount. Use the amount printed on the Supplement Facts panel, not the front-of-pack compound weight. Reference amounts are what trials studied or official limits, not advice for you. We don't rank or link products on this page.

Frequently asked questions

Does horny goat weed work for erections?

There is no published placebo-controlled human trial of Epimedium alone for erections. Its icariin inhibits PDE5 in lab tests and helped nerve-injured rats, but that has not been confirmed in people.[4][5]

Is icariin like Viagra?

Both act on PDE5 in the lab, but icariin was about 80 times weaker than sildenafil, and icariin itself was not detected in blood after an oral Epimedium extract.[4][2]

Does horny goat weed raise testosterone?

No human trial of Epimedium alone measuring testosterone was found. The rat study measured testosterone, but rat data do not show an effect in people.[5]

Is horny goat weed safe?

A 6-week trial in 58 women found no adverse symptoms or lab changes, but case reports describe severe muscle injury and psychosis, and a horny goat weed product was recalled (notice posted by FDA) after it was found to contain sildenafil.[2][7][6][9]

Does it help bones?

In a 24-month trial, postmenopausal women given icariin 60 mg/day with soy isoflavones kept their bone density while the placebo group lost bone. Icariin's own role cannot be separated.[1]

How much icariin is in a typical capsule?

Labels list 500 mg of extract at 10% icariin (50 mg) per capsule, twice daily, which is about 100 mg icariin a day.[10]

Sources

  1. [1]Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.. J Bone Miner Res, 2007. RCT PMID 17419678
  2. [2]Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women.. Phytomedicine, 2021. RCT PMID 34352588
  3. [3]A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom (Ganoderma lucidum), Stinging Nettle (Urtica dioica), and Epimedium (Epimedium sagittatum).. Int J Environ Res Public Health, 2021. pilot-RCT PMID 33915962
  4. [4]Potent inhibition of human phosphodiesterase-5 by icariin derivatives.. J Nat Prod, 2008. animal-study PMID 18778098
  5. [5]Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo.. J Sex Med, 2010. animal-study PMID 20141584
  6. [6]New-Onset Psychosis in a Person with Parkinson's Disease after "Horny Goat Weed" Use.. Mov Disord Clin Pract, 2026. observational PMID 40916762
  7. [7]Herba Epimedium (Horny Goat Weed) Toxicity With Severe Muscle Spasms and Elevated Creatine Kinase and Creatinine: A Case Report.. Cureus, 2025. observational PMID 40546602
  8. [8]Herba Epimedii and Increased Opioid Cravings While on Buprenorphine: A Case Report.. Cureus, 2024. observational PMID 38327958
  9. [9]EnShiShiXiangNiShangMaoYouXianGongSi Issues Voluntary Nationwide Recall of ENDURANCE BOOST WITH HORNY GOAT WEED Capsules Due To Presence of Undeclared Propoxyphenylsildenafil and Sildenafil. U.S. Food and Drug Administration, 2025. safety-communication
  10. [10]Standardized Horny Goat Weed (Nature's Way), DSLD label 79133: 500 mg Epimedium extract standardized to 10% icariin (50 mg) per capsule. NIH Office of Dietary Supplements, Dietary Supplement Label Database, 2017. label

What changed

  1. October 13, 2026 · whoShouldAvoid, faq · independent reviewIndependent review: the 2025 Endurance Boost recall was a voluntary company recall posted by FDA, not an FDA recall; wording corrected. All PMIDs re-checked.Writer: Kymata Labs Editorial · No credentialed reviewer yet
  2. October 13, 2026 · all · reviewAdversarial review pass: every evidence row, key fact, form, label line, FAQ and insight re-read against its PubMed abstract, PMC full text, fact sheet, FDA page or DSLD label; all PMIDs re-checked by esummary (titles and years match; no retraction or expression-of-concern flags). Fixed: BSAP result restated as an association (as in the abstract), Gulf War illness tolerability wording narrowed, muscle-injury outcome restated as improvement in hospital. Page set indexable.Writer: Kymata Labs Editorial · No credentialed reviewer yet
  3. October 13, 2026 · all · new pageFirst draft. Every PMID checked against NCBI E-utilities esummary (title and year from the record) and abstracts read for each cited row; Gulf War illness doses and completer count from the PMC full text (PMC8037868); psychosis and muscle-injury case details from PMC full texts (PMC12911459, PMC12182873). FDA recall page and NIH DSLD label read directly. No NCCIH or NIH ODS fact sheet covers Epimedium. PubMed searches found no placebo-controlled human trial of Epimedium alone for sexual function.Writer: Kymata Labs Editorial · No credentialed reviewer yet

How we write, grade and correct these pages: editorial and evidence policy.

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Supplements and vitamins: every page →Supplement & Nutrient Encyclopedia →Browse all topics →

Evidence-graded supplement stacks →